Anthracycline-induced cardiotoxicity: A case report and review of literature
CONCLUSION: We present a case of 35-year-old African American female developing cardiogenic shock shortly after receiving a cumulative dose of 450 mg/m2 doxorubicin over 9 mo. Cardiac monitoring and management of patients receiving anthracycline chemotherapy have been an area of intense research since introduction of these agents in clinical practice. We have reviewed literature and recent advances in the prediction and prevention of AIC. Although risk factors currently identified can help stratify patients who need closer monitoring, there are limitations to our current understanding and further research is needed in this field.PMID:33552401 | PMC:PMC7821007 | DOI:10.4330/wjc.v13.i1.28
Source: World Journal of Cardiology - Category: Cardiology Authors: Esther G Chong Eric H Lee Reena Sail Laura Denham Gayathri Nagaraj Chung-Tsen Hsueh Source Type: research
More News: Bone Cancers | Cancer | Cancer & Oncology | Cardiogenic Shock | Cardiology | Chemotherapy | Congestive Heart Failure | Emergency Medicine | Heart | Heart Failure | Liver | Osteosarcoma | Respiratory Medicine | Urology & Nephrology